Interim / Quarterly Report • Sep 20, 2023
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
XTPL S.A.

XTPL Spółka Akcyjna, a joint stock company having its registered office at ul. Stabłowicka 147, 54-066 Wrocław, entered in the business register of the National Court Register kept by the District Court for Wrocław-Fabryczna, VI Commercial Division of the National Court Register under KRS No. 0000619674 ("XTPL", "XTPL S.A.", "Company", "Entity", "Parent Company", "Issuer"), NIP: 9512394886, REGON: 361898062.
As at June 30, 2023 ("Balance Sheet Date"), the share capital of XTPL S.A. amounted to PLN 202,922.20 and consisted of 2,029,222 shares with a nominal value of PLN 0.10 each ("Shares").
XTPL S.A. forms the XTPL Group ("Group", "XTPL Group"). This document contains the interim condensed standalone financial statements of XTPL.
The Group includes the parent company and subsidiaries: XTPL Inc. with its registered office in the USA, and TPL Sp. z o.o. with its registered office in Wrocław, fully controlled by XTPL S.A. ("Subsidiaries", "Subsidiary Undertakings", "XTPL Inc.", "TPL sp. z o.o.").
This report ("Report") is interim condensed standalone financial statements of XTPL S.A. for the period from January 1, 2022 to June 30, 2023 ("Reporting Period") prepared in accordance with the International Financial Reporting Standards approved for application in the EU.
Unless indicated otherwise, the source of data in the Report is XTPL S.A. The Report publication date ("Report Date") is September 20, 2023. As at the Report Date, the share capital of XTPL S.A. amounts to PLN 230,422.20 and consists of 2,304,222 shares with a nominal value of PLN 0.10 each ("Shares").
"Regulation on current and periodic reports" means the Finance Minister's Regulation of March 29, 2018 on current and periodic reports released by the issuers of securities and the conditions for equivalent treatment of the information required by the laws of non-member states.
"Accounting Act" – the Accounting Act of September 29, 1994.
Due to the fact that the activities of XTPL S.A. have a dominant impact on the Group's operations, the information presented in the Management Report relates to both to XTPL S.A. and XTPL Group, unless stated otherwise.
Unless stated otherwise, the financial data are presented in thousands.

| SELECTED STANDALONE FIGURES 5 | |
|---|---|
| KEY INFORMATION ABOUT THE ISSUER 6 | |
| INTERIM CONDENSED STANDALONE FINANCIAL STATEMENTS 10 | |
| ADDITIONAL INFORMATION 28 | |
| MANAGEMENT BOARD'S STATEMENTS 30 | |
| MANAGEMENT BOARD'S STATEMENT ON THE STATUTORY AUDITOR 31 | |
| MANAGEMENT BOARD'S OPINION 32 | |
| APPROVAL FOR PUBLICATION 33 |

| Figures in PLN thousand | January 1 – June 30, 2023 | January 1 – June 30, 2022 | ||
|---|---|---|---|---|
| PLN | EUR | PLN | EUR | |
| Net revenue from the sale of products and services | 5,532 | 1,199 | 2,970 | 640 |
| Revenue from grants | 1,356 | 294 | 1,816 | 391 |
| Profit (loss) on sales | 3,084 | 669 | 1,411 | 304 |
| Profit (loss) before tax | -1,833 | -397 | -2,801 | -603 |
| Profit (loss) after tax | -1,833 | -397 | -2,801 | -603 |
| Depreciation/amortization | 713 | 155 | 433 | 93 |
| Net cash flows from operating activities | -458 | -99 | 74 | 16 |
| Net cash flows from investing activities | -2,356 | -511 | -943 | -203 |
| Net cash flows from financing activities | -219 | -47 | -286 | -62 |
| Figures in PLN thousand | June 30, 2023 | December 31, 2022 | ||
| Equity | 2,321 | 522 | 4,153 | 886 |
| Short-term liabilities | 12,881 | 2,894 | 7,076 | 1,509 |
| Long-term liabilities | 3,188 | 716 | 6,447 | 1,375 |
| Cash and cash equivalents | 2,883 | 648 | 5,891 | 1,256 |
| Short-term receivables | 3,289 | 739 | 2,577 | 549 |
| Long-term receivables | 176 | 40 | 366 | 78 |

| Business name: | XTPL Spółka Akcyjna |
|---|---|
| Registered Office: | Wrocław |
| Address: | Stabłowicka 147, 54-066 Wrocław |
| KRS: | 0000619674 |
| NIP: | 9512394886 |
| REGON: | 361898062 |
| Registry Court: | District Court for Wrocław-Fabryczna, VI Comm. Div. of the National Court Register |
| Share capital: | PLN 230,422.20, paid up in full. |
| Phone number: | +48 71 707 22 04 |
| Website: | www.xtpl.com |
| Email: | [email protected] |
The Company has the status of a public company. Since 20 February 2019, its shares have been listed on the regulated (parallel) market operated by the Warsaw Stock Exchange.
As regards financial reporting, the Company uses IASs/ IFRSs.
The Company's financial year is from January 1 to December 31.
As at the Balance Sheet Date and the Report Date, the Management Board performed its duties in the following composition:
| As at the Balance Sheet Date: | As at the Report Date: |
|---|---|
| Filip Granek, PhD, CEO | Filip Granek, PhD, CEO |
| Jacek Olszański – Management Board Member |
Jacek Olszański – Management Board Member |
As at the Balance Sheet Date and as at the Report Date, the Supervisory Board performed its duties in the following composition:
| As at the Balance Sheet Date: | As at the Report Date: |
|---|---|
| Wiesław Rozłucki, PhD – Chairman of the Supervisory | Wiesław Rozłucki, PhD – Chairman of the Supervisory |
| Board, an independent Supervisory Board Member | Board, an independent Supervisory Board Member |
| Bartosz Wojciechowski, PhD – Deputy Chairman of the | Bartosz Wojciechowski, PhD – Deputy Chairman of the |
| Supervisory Board | Supervisory Board |
| Andrzej Domański – Deputy Chairman of the Supervisory | Andrzej Domański – Deputy Chairman of the Supervisory |
| Board, an independent Supervisory Board Member | Board, an independent Supervisory Board Member |
| Beata Turlejska – Supervisory Board Member | Beata Turlejska – Supervisory Board Member |
|---|---|
| Piotr Lembas – an independent Supervisory Board | Piotr Lembas – an independent Supervisory Board |
| Member | Member |
| Prof. Herbert Wirth – an independent Supervisory Board | Prof. Herbert Wirth – an independent Supervisory Board |
| Member | Member |
The corporate group XTPL S.A. was established on January 31, 2019.
On January 31, 2019, XTPL S.A. acquired all shares in XTPL Inc., a newly formed entity based in the state of Delaware, United States. The share capital of XTPL Inc. is USD 5,000. XTPL S.A. acquired 100% of the stock at the nominal price. XTPL INC. is consolidated using the line-by-line method.
On November 3, 2020, the Issuer acquired all shares in TPL sp. z o.o. based in Wrocław. The shares in the share capital of TPL were acquired without remuneration, but as a donation from each of the TPL shareholders to the Issuer.
Under an agreement with the Issuer, TPL acts as the administrator of the Issuer's employee incentive scheme, which is an important part of managing and motivating the Issuer's employees and collaborators, contributing to the Issuer's business development and value generation.
Structure of XTPL Group as at the Report Date:

Not applicable. Neither the Parent Company nor its Subsidiaries have any branches.

Not applicable. As part of the group, no transaction was made with any related party on non-commercial terms.
No significant judicial, arbitration or administrative proceedings are pending in relation to liabilities or receivables of the Issuer.
Not applicable. Neither the Issuer nor its Subsidiary provided any guarantees in the Reporting Period.
Not applicable.
The Management Board's position regarding the possibility of achieving the previously published performance forecasts for a given year, in the light of the results presented in the Report in relation to the forecast results, i.e. preliminary estimates of consolidated revenues from the sale of products and services achieved by the Company in Q2 2023 and H1 2023, published in ESPI Current Report No. 38/2023 of July 18, 2023:
The preliminary data disclosed to the public were substantially in line with the actual data.
Not applicable. The Company's and the Group's activity is not subject to seasonality or business cycles.
Not applicable. None in the Reporting Period.
Employment as at the Balance Sheet Date – 54 people.


| ASSETS | NOTE | 30.06.2023 | 31.12.2022 |
|---|---|---|---|
| PLN '000 | |||
| Non-current assets | 10,135 | 8,103 | |
| Property, plant and equipment | 2 | 4,539 | 4,298 |
| Intangible assets | 1 | 5,420 | 3,439 |
| Long-term receivables | 6 | 176 | 366 |
| Current assets | 8,255 | 9,573 | |
| Inventories | 7 | 1,849 | 948 |
| Trade receivables | 643 | 776 | |
| Other receivables | 2,646 | 1,801 | |
| Cash and cash equivalents | 2,883 | 5,891 | |
| Other assets | 234 | 157 | |
| Total assets | 18,390 | 17,676 |
| EQUITY AND LIABILITIES | NOTE | 30.06.2023 | 31.12.2022 |
|---|---|---|---|
| PLN '000 | |||
| Total equity | 2,321 | 4,153 | |
| Share capital | 203 | 203 | |
| Supplementary capital | 1,531 | 1,531 | |
| Reserve capital | 2,792 | 5,048 | |
| Retained earnings, including: | -372 | -2,629 | |
| - current period result | -1,833 | -2,257 | |
| Long-term liabilities | 3,188 | 6,447 | |
| Long-term financial liabilities | 331 | 3,573 | |
| Deferred income in respect of grants | 2,857 | 2,874 | |
| Short-term liabilities | 12,881 | 7,076 | |
| Trade liabilities | 2,316 | 1,429 | |
| Short-term financial liabilities | 3,958 | 337 | |
| Other liabilities | 4,266 | 3,021 | |
| Deferred income in respect of grants | 2,341 | 2,289 | |
| Total equity and liabilities | 18,390 | 17,676 | |
| shaping global nanofuture | |
|---|---|
PLN000<br>PLN000Continued operations Sales 13 6,888 4,786 Revenue from the sale of products and services 13 5,532 2,970 Revenue from grants 1,356 1,816 Cost of sales 14 3,804 3,375 Research and development expenses 14 2,604 3,144 Cost of finished goods sold 14 1,200 231 Gross profit (loss) 3,084 1,411 General and administrative expenses 14 4,597 4,103 Other operating income 5 – Other operating costs 25 1 Operating profit (loss) -1,533 -2,693 Financial revenues 9 61 Financial expenses 309 169 Profit/ loss before tax -1,833 -2,801 Income tax – – Net profit (loss) on continued operations -1,833 -2,801 Discontinued operations – – Net profit (loss) on discontinued operations Net profit (loss) on continued and discontinued operations -1,833 -2,801 Other comprehensive income – – Total comprehensive income -1,833 -2,801 Net profit (loss) per share (in PLN) On continued operations Ordinary -0.90 -1.38 Diluted -0.88 -1.35 On continued and discontinued operations Ordinary -0.90 -1.38 Diluted -0.88 -1.35 number of shares 2,029,222 2,029,222 number of shares to calculate diluted profit (loss) per share * 2,074,877 2,077,870 |
1.01.2023 - | 1.01.2022 - | ||
|---|---|---|---|---|
| STATEMENT OF COMPREHENSIVE INCOME | NOTE | 30.06.2023 | 30.06.2022 | |
| Share capital | Supplementary capital |
Reserve capital | Retained earnings |
Total | |
|---|---|---|---|---|---|
| IN EQUITY | |||||
| PLN`000 | |||||
| As at January 1, 2023 | 203 | 1,531 | 5,048 | -2,629 | 4,153 |
| Comprehensive income: | – | – | – | -1,833 | -1,833 |
| Profit (loss) after tax | – | – | – | -1,833 | -1,833 |
| Other comprehensive income | – | – | – | – | – |
| Transactions with owners: | – | – | -2,257 | 2,257 | – |
| Issue of shares | – | – | – | – | – |
| Incentive scheme | – | – | – | – | – |
| Distribution of profit | – | – | -2,257 | 2,257 | – |
| As at June 30, 2023 | 203 | 1,531 | 2,792 | -2,205 | 2,321 |
| As at January 1, 2022 | 203 | 8,129 | 3,926 | -6,970 | 5,288 |
| Comprehensive income: | – | – | – | -2,801 | -2,801 |
| Profit (loss) after tax | – | – | – | -2,801 | -2,801 |
| Other comprehensive income | – | – | – | – | – |
| Transactions with owners: | – | -6,598 | 1,149 | 6,598 | 1,149 |
| Issue of shares | – | – | – | – | – |
| Incentive scheme | – | – | 1,149 | – | 1,149 |
| Distribution of profit | – | -6,598 | – | 6,598 | – |
| As at June 30, 2022 | 203 | 1,531 | 5,075 | -3,173 | 3,636 |
3.4 Interim condensed standalone statement of cash flows
| 1.01.2023 | 1.01.2022 | ||
|---|---|---|---|
| NOTE | – | – | |
| STATEMENT OF CASH FLOWS | 30.06.2023 | 30.06.2022 | |
| PLN'000 | PLN'000 | ||
| Cash flows from operating activities | 15 | ||
| Profit (loss) before tax | -1,833 | -2,801 | |
| Total adjustments: | 1,375 | 2,874 | |
| Depreciation/amortization | 673 | 433 | |
| FX gains (losses) | -5 | -40 | |
| Interest and profit distributions (dividends) | 171 | 51 | |
| Profit (loss) on investing activities | 47 | 114 | |
| Change in the balance of provisions | 135 | 85 | |
| Change in the balance of inventories | -901 | -347 | |
| Change in the balance of receivables | -701 | 923 | |
| Change in short-term liabilities, except bank and other loans | 1,999 | 40 | |
| Change in other assets | -78 | -95 | |
| Change in the balance of grants to be settled | 35 | 561 | |
| Incentive scheme valuation | – | 1,149 | |
| Income tax paid | – | – | |
| Total cash flows from operating activities | -458 | 73 | |
| Cash flows from investing activities | 15 | ||
| Inflows | 180 | 270 | |
| Disposal of tangible and intangible assets | – | 169 | |
| Repayment of long-term loans | 180 | 100 | |
| Interest on financial assets | – | 1 | |
| Outflows | 2,536 | 1,212 | |
| Acquisition of tangible and intangible fixed assets | 2,469 | 1,127 | |
| Acquisition of financial assets | 67 | – | |
| Long-term loans granted | – | 85 | |
| Other investment outflows | – | – | |
| Total cash flows from investing activities | -2,356 | -942 | |
| Cash flows from financing activities | 15 | ||
| Inflows | 248 | – | |
| Contributions to capital | – | – | |
| Bank and other loans | 248 | – | |
| Outflows | 467 | 286 | |
| Repayment of bank and other loans | – | – | |
| Finance lease payments | 378 | 267 | |
| Interest | 89 | 19 | |
| Total cash flows from financing activities | -219 | -286 | |
| Total cash flows from investing activities | -3,033 | -1,155 | |
| Change in cash and cash equivalents: | -3,008 | -1,144 | |
| – change in cash due to FX differences | 25 | 11 |
| Cash and cash equivalents at the beginning of the period | 5,920 | 4,477 |
|---|---|---|
| Cash and cash equivalents at the end of the period, including: | 2,887 | 3,322 |
| – restricted cash | 576 | 1,364 |
| OTHER INTANGIBLE ASSETS | figures in PLN thousand |
30.06.2023 | 31.12.2022 |
|---|---|---|---|
| Acquired concessions, patents, licenses and | – | 2 | |
| similar rights Intellectual property rights |
– | – | |
| Completed development | 2,213 | 2,398 | |
| In-process development expenditure | 3,207 | 1,039 | |
| Total (net) | 5,420 | 3,439 | |
| Amortization to-date | 1,932 | 1,745 | |
| Total (gross) | 7,352 | 5,184 |
All intangible assets are the property of the Company; none of these assets are used based on any rental, lease or a similar contract. The intangible assets are not used as collateral. As at June 30, 2023, the Company did not have any agreements whereby it would be required to purchase any intangible assets. In 2023 and 2022, no impairment charges were posted for intangible assets.
| PROPERTY, PLANT AND EQUIPMENT | figures in PLN thousand |
30.06.2023 | 31.12.2022 |
|---|---|---|---|
| Technical equipment and machines | 259 | 280 | |
| Vehicles | 95 | – | |
| Other tangible assets | 3,567 | 1,135 | |
| Tangible assets under construction | 618 | 2,882 | |
| Total (net) | 4,539 | 4,297 | |
| Depreciation to-date | 2,838 | 2,271 | |
| Total (gross) | 7,377 | 6,568 | |
Tangible assets under construction include expenditure related to the construction of the prototype printing device as part of the ongoing subsidy project. No tangible assets are used as collateral. In 2023 and 2022, no impairment charges were posted for tangible assets.
| SIGNIFICANT ACQUISITIONS OF TANGIBLE ASSETS |
figures in PLN thousand |
01.01.2023 - 30.06.2023 |
01.01.2022 - 31.12.2022 |
|---|---|---|---|
| XTPL printers, 3D | 40 | – | |
| Computer sets | 73 | 197 | |
| Rheometer | 108 | 162 |
| Laser measuring system | 92 | 144 |
|---|---|---|
| Centrifuge | 426 | 592 |
| Anti-vibration system | – | 46 |
| Car | 98 | – |
| Pressure control system and other | – | 15 |
| Confocal microscope | 172 | – |
| Other laboratory equipment | – | 71 |
| Glovebox | 328 | – |
| Total significant acquisitions | 1,337 | 1,227 |
In the reporting period, the Company did not incur any significant liabilities on account of purchase of tangible assets. As at June 30, 2023, the Company did not have any agreements whereby it would be required to purchase any fixed assets.
In the reporting period no changes were made in the classification of financial assets.
Loan granted to the subsidiary.
Due to the results of the subsidiary XTPL Inc., the Management Board of XTPL S.A. assessed the value of the loans granted to the subsidiary in terms of impairment of assets. The Management Board is of the opinion that the probability of XTPL Inc. obtaining revenues as a result of a license agreement signed by the subsidiary in 2023 is low, and for this reason decided to create an impairment allowance for full value of the tranches paid out from January 1, 2023 to June 30, 2023, i.e. PLN 54 thousand.
| Long-term receivables | figures in PLN thousand |
30.06.2023 | 31.12.2022 |
|---|---|---|---|
| Loans granted | 143 | 322 | |
| Security deposits | 33 | 44 | |
| Shares | – | – | |
| Total long-term receivables | 176 | 366 |

In the Reporting Period, no write-down (impairment allowance) of inventories was created or reversed.
| CHANGE IN THE BALANCE OF PROVISIONS | figures in PLN thousand |
01.01.2023 - 30.06.2023 |
01.01.2022 - 31.12.2022 |
|---|---|---|---|
| Balance at the beginning of the period | 272 229 |
||
| increased/ created | 138 | 152 | |
| utilization | – | – | |
| release | – | 109 | |
| Balance at the end of the period | 410 | 272 |
The change in provisions presented in the table above relates to provisions created for unused annual leaves by the Company's employees and provisions for business travel expenses. The above provisions are presented in the statement of financial position under other liabilities.
Either in the reporting period or in prior years, the Company did not create any provisions for restructuring costs.
In the reporting period no changes in estimates were made.
In the first half of 2023, no corrections were made on account of errors from previous periods.
In the reporting period no transfers took place between individual fair value hierarchy levels in respect of financial instruments.
| Book value | Fair value | ||||
|---|---|---|---|---|---|
| Category | 30.06.2023 | 31.12.2022 | 30.06.2023 | 31.12.2022 | |
| Financial assets Loans granted |
WwgZK | 143 | 322 | 143 | 322 |
| Trade receivables | WwgZK | 643 | 776 | 643 | 776 |
|---|---|---|---|---|---|
| Other receivables | WwgZK | 2,646 | 1,801 | 2,646 | 1,801 |
| Cash and cash equivalents | WwgZK | 2,883 | 5,891 | 2,883 | 5,891 |
| Total | 6,315 | 8,790 | 6,315 | 8,790 | |
| Financial liabilities | |||||
| Interest bearing bank and other loans | PZFwgZK | 248 | – | 248 | – |
| Bond liabilities | WwWGpWF | 3,263 | 3,180 | 3,263 | 3,180 |
| Lease liabilities | according to IFRS 16 |
778 | 729 | 778 | 729 |
| Trade liabilities | PZFwgZK | 2,316 | 1,429 | 2,316 | 1,429 |
| Other liabilities | PZFwgZK | 4,266 | 3,021 | 4,266 | 3,021 |
| Total | 10,871 | 8,359 | 10,871 | 8,359 |
Abbreviations used:
WwgZK – measured at amortized cost
PZFwgZK – Other liabilities measured at amortized cost
WwWGpWF – Financial assets/ liabilities measured at fair value through profit or loss
Fair value of financial instruments that the Company held as at June 30, 2023 and December 31, 2022 was not materially different from the values presented in the financial statements for the respective years, which is due to the following circumstances:
– with regard to short-term instruments, the potential effect of the discount is not material;
– the instruments relate to the transactions concluded on market terms.
Bond liabilities were measured at fair value due to the fact that they represent complex financial instruments, as series A registered bonds are convertible into series U shares of the Company. At the initial recognition, the value of the complex financial instrument was assigned to equity and to liabilities.
| NET REVENUE FROM SALES | figures in PLN thousand |
01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
|---|---|---|---|
| Research and development revenue | 1,595 | 2,356 | |
| Revenue from the sale of products | 3,937 | 614 | |
| Revenue from grants | 1,356 | 1,816 | |
| Total net revenue from sales | 6,888 | 4,786 |
The total value of grants obtained in the reporting period amounted to PLN 1,400 thousand. Out of this figure, PLN 44 thousand represents advances to be settled in future periods, recognized under liabilities in the statement of financial position, as well as refund of costs incurred for the construction of a tangible asset, which in accordance with IFRS 20 "Grants" constitutes a grant in relation to assets, and is also recognized as at the balance sheet date in the liabilities of the statement of financial position. Grants in relation to depreciable assets will be recognized in the Company's profit or loss over the subsequent periods in proportion to the recognition of depreciation charges on those assets.
| OPERATING COSTS | figures in PLN thousand |
01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
|---|---|---|---|
| Depreciation/ amortization, including | 713 | 433 | |
| – depreciation of tangible assets | 526 | 243 | |
| – amortization of intangible assets | 187 | 190 | |
| Use of raw materials and consumables | 1,933 | 1,242 | |
| External services | 2,662 | 2,206 | |
| Cost of employee benefits | 4,537 | 3,548 | |
| Taxes and charges | 46 | 60 | |
| Other costs by type | 509 | 255 | |
| Value of goods and materials sold | – | – | |
| Total costs by type, including: | 10,400 | 7,744 | |
| Items reported as research and development costs |
2,604 | 3,144 | |
| Items reported as cost of finished goods sold | 1,200 | 231 | |
| Items reported as general and administrative expenses |
4,597 | 4,103 | |
| Change in finished goods | -169 | – | |
| Cost of producing services for internal needs of the entity | 2,168 | 266 |
| figures in PLN thousand |
01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
|
|---|---|---|---|
| PBT presented in the statement of comprehensive income |
-1,833 | -2,801 | |
| PBT presented in the statement of cash flows | -1,833 | -2,801 | |
| INTEREST AND DIVIDENDS IN THE STATEMENT OF CASH FLOWS |
01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
|
| Realized interest on financing activities | 89 | 19 | |
| Realized interest on investing activities | – | -1 | |
| Unrealized interest on financing activities | 84 | 36 | |
| Unrealized interest on investing activities | -2 | -3 | |
| Total interest and dividends: | 171 | 51 |
| CHANGE IN THE BALANCE OF RECEIVABLES | 01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
|---|---|---|
| Change in the balance of trade receivables | 133 | 1,281 |
| Other receivables | -834 | -358 |
| Total change in the balance of receivables | -701 | 923 |
| CHANGE IN THE BALANCE OF LIABILITIES | 01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
| Change in the balance of trade liabilities | 887 | 96 |
| Other liabilities Total change in the balance of liabilities: |
1,112 1,999 |
-56 40 |
| Cash and cash equivalents at the end of the period |
01.01.2023 – 30.06.2023. |
01.01.2022 – 30.06.2022. |
| Statement of cash flows | 2,887 | 3,322 |
In its statement of cash flows the Company recognizes inflows and expenses related to received grants to its operating activities.
| 2 QUARTERS OF 2023 | figures in PLN thousand |
To subsidiaries |
To joint ventures |
To key management personnel* |
To other related entities ** |
|---|---|---|---|---|---|
| Purchase of services | 180 | – | – | – | |
| Loans granted | 67 | – | – | – | |
| Financial expenses – interest on loans | 22 | – | – | – | |
| 2 QUARTERS OF 2022 | figures in PLN thousand |
To subsidiaries |
To joint ventures |
To key management personnel* |
To other related entities ** |
| Purchase of services | 180 | – | – | – | |
| Loans granted | 85 | – | – | – | |
| Financial expenses – interest on loans | 32 | – | – | – |
* the item includes persons who have the authority and responsibility for planning, managing and controlling the company's activities
** the item includes entities linked through key management
Terms of related party transactions

Sales to and purchases from related parties are made on an arm's length basis. Any overdue liabilities/ receivables existing at the end of the period are interest-free and settled on cash or non-cash basis. The company does not charge late interest from other related entities. Receivables from or liabilities to related parties are not covered by any guarantees given or received. They are not secured in any other way either.
At the end of the Reporting Period, i.e. on June 30, 2023, the Company created an impairment allowance for tranches of the loans granted to the related party, covering the principal amount and interest. In each financial year, an assessment is carried out which involves examining the financial position of the related party and the market in which it operates.
| Deferred income tax assets due to negative temporary differences |
Statement of financial position as at |
Impact on the statement of comprehensive income |
|
|---|---|---|---|
| 30.06.2023 | 31.12.2022 | 01.01.2023 - 30.06.2023 |
|
| Due to differences between the tax value and | |||
| the carrying amount: | |||
| Provisions for payroll and similar costs (including bonuses, jubilee awards, non-staff expenses) |
– | – | – |
| Accruals for unused annual leaves | 77 | 51 | 26 |
| Provision for remuneration | 4 | 6 | -2 |
| Loan valuation | – | 6 | -6 |
| Provision for the cost external services | 14 | – | 14 |
| Total deferred tax assets | 95 | 63 | 32 |
| Set-off with a deferred tax liability | -95 | -63 | -32 |
| Net deferred tax assets | – | – | – |
The Company is exposed to risk in each area of its operations. With understanding of the threats that originate through the Group's exposure to risk and the rules for managing those threats the Group can run its operations more effectively. Financial risk management includes the processes of identification, assessment, measurement and management of this risk. The main financial risks to which the Company is exposed include: Market risks:
The risk management process is supported by appropriate policies, organizational structure and procedures.

The company actively manages the market risk to which it is exposed. The objectives of the market risk management process are to:
• support the strategic decision-making process in the area of investment activity taking into account the sources of investment financing
All market risk management objectives should be considered jointly, and their primarily dependent on the Company's internal situation and market conditions.
In the period from January to June 2023, the Company did not invest in any debt instruments and, therefore, is not exposed to any price risk.
The Company is exposed to currency risk in respect of the transactions it concludes. Such risk arises when the Company makes purchases in currencies other than the valuation currency.
Deposit transactions are made with institutions with a strong and stable market position. The instruments used – shortterm, fixed-rate transactions – ensure full security.
The Company monitors the risk of a lack of funds using the periodic liquidity planning tool. This tool takes into account the maturity dates of both investments and financial assets (e.g. accounts receivable, other financial assets) and projected cash flows from operating activities.
The Company seeks to maintain a balance between continuity and flexibility of financing by using different sources of financing, such as lease agreements.
The Company is exposed to financing risk due to the possibility that in the future it might not receive sufficient cash to fund commercialization of its research and development projects.
In order to mitigate the credit risk related to cash and cash equivalents deposited in banks, loans granted, deposits paid in respect of rental contracts and performance security as well as trade credit, the Company:
• cooperates with banks and financial institutions with a known financial position and established reputation
• analyzes the financial position of its counterparties based on publicly available data as well as through business intelligence agencies
• in the event of a customer's insolvency risk, the Company secures its receipts through bank guarantees or corporate guarantees.
At the reporting date there are no court proceedings pending whose value would be considered material. Furthermore, in the period covered by the interim report no material settlements were made on account of court cases.

In the first half of 2023, no significant changes were identified in the economic position or operating conditions which would have a material impact on the fair value of the Company's financial assets and liabilities.
Contingent liabilities granted by the Parent Company were in the form of promissory notes together with promissory note declarations to secure the contracts for co-financing projects financed by the EU as well as a bank loan agreement. The change in the value of contingent liabilities in relation 31 December 2022 amounts to PLN 1,400 thousand. It is caused by the payment of the next two tranches of grants and advances for grant settlement. At the Balance Sheet Date and until the date of approval of the financial statements for publication, no events occurred that could result in materialization of the above contingent liabilities. As at the date of approval of the financial statements there were no undisclosed liabilities resulting from any agreements of material value.
| CONTINGENT LIABILITIES | 30.06.2023 | 31.12.2022 |
|---|---|---|
| Promissory notes | 20,525 | 19,125 |
| Total contingent liabilities | 20,525 | 19,125 |
In the Reporting Period, the Company did not grant any instruments and did not account for or recognize the cost of the incentive scheme for employees and collaborators based on the Parent Company's shares.
The Company's activity is not subject to seasonality or business cycles.
In the reporting period, no extraordinary events occurred that would affect the financial statements.
In the reporting period no events took place in connection with an issue, redemption or repayment of debt or equity securities.

In the reporting period the Company did not pay or declare any dividends.
The entity's reporting segments are based on product groups.
As at the Reporting Date, the Company distinguished three product groups:
– sale/ lease of the Delta Printing System
– silver-based conductive nanoinks;
– research services related to (i) testing the suitability of XTPL S.A. technology to solve technological production problems and (ii) development of new nanoink formulations.
| SALES REVENUE BY SEGMENTS | 01.01.2023 - 30.06.2023 |
01.01.2022 - 30.06.2022 |
|---|---|---|
| Nanoinks | 212 | 84 |
| Printer sale/ lease | 3,725 | 530 |
| Research and development services | 1,595 | 2,356 |
| TOTAL | 5,532 | 2,970 |
No such events occurred in the reporting period.
This financial report for the period from January 1, 2023 to June 30, 2022 was approved for publication by the Company's Management Board on September 20, 2022.
| Deferred tax liability caused by positive temporary differences |
Statement of financial position as at |
|
|---|---|---|
| 30.06.2023 31.12.2022 |
01.01.2023 - 30.06.2023 |
|
| In respect of: Interest on loans and deposits |
9 – |
9 |
| Leased tangible assets | 86 | 63 | 23 |
|---|---|---|---|
| Total deferred tax liability | 95 | 63 | 32 |
| Set-off with deferred tax assets | -95 | -63 | -32 |
| Net deferred tax liability | – | – | – |
| Date | Event | Current Report |
|---|---|---|
| July 12, 2023 | With reference to ESPI Current Report No. 30/2023 of June 22, 2023 | ESPI Current |
| and ESPI Current Report No. 27/2023 of June 12, 2023 and earlier ones, | Report No. | |
| the Issuer's Management Board reported that on July 12, 2023 the | 37/2023 of July | |
| placement of the Issuer's series V shares had been finalized. | 12, 2023 | |
| On July 12, 2023, the Issuer's Management Board made a statement on | ||
| the final determination of the share capital in the Company's Articles of | ||
| Association to the effect that the Company's share capital is PLN | ||
| 230,422.20 and is divided into 2,304,222 ordinary bearer shares with a | ||
| nominal value of PLN 0.10 each. | ||
| July 24, 2023 | The Company confirmed the order placed by the CENIMAT i3N scientific | ESPI Current |
| research center in Portugal for the delivery of the Delta Printing System. | Report No. | |
| 39/2023 of July | ||
| The Delta Printing System will be used by scientists from the Advanced | 24, 2023 | |
| Functional Materials for Micro and Nanotechnologies (AFMMN) Group, | ||
| which is one of three Research Teams at CENIMAT i3N in Portugal. The | ||
| AFMMN Group is focused on semiconductor fabrication and analysis | ||
| processes, and has extensive experience in developing materials for key | ||
| enabling technologies. The efforts are focused on the properties of | ||
| materials in the nanoscale for industries such as electronics and | ||
| optoelectronics. The device is to be delivered by the end of 2023. | ||
| CENIMAT i3N is a Portuguese scientific research center sponsored by | ||
| the Ministry of Science, Technology and Higher Education, through the | ||
| Foundation for Science and Technology. For many years now, it has | ||
| been the world's leading center of engineering and materials science. | ||
| July 26, 2023 | The Company received information that the United States Patent and | ESPI Current |
| Trademark Office had granted it patent for the method of characterizing | Report No. | |
| and optimizing ink flow in the printing head. The patent was granted in | 40/2023 of July | |
| response to the patent application "Method of estimating an output | 27, 2023 | |
| diameter of a capillary tube, and related methods". | ||
| The application procedure for this patent was initiated on June 8, 2020. | ||
| This is also the date when patent protection started for the invention. | ||
| The final formal requirement for obtaining the patent is to pay the | ||
| patent fee by October 17, 2023. Should the requirement not be met, | ||
| the Company will communicate this in a separate current report. | ||
| August 3, 2023 | With reference to ESPI Current Report No. 37/2023 of July 12, 2023 and | ESPI Current |
| ESPI Current Report No. 26/2023 of June 12, 2023, the Company's | Report No. | |
| Management Board reported that on August 3, 2023 the registry court | 41/2023 of | |
| had registered amendments in the Articles of Association of XTPL S.A. – | August 3, 2023 | |
| § 5 of the Company's Articles of Association) in connection with |

| Resolution No. 03/06/2023 of the Issuer's Extraordinary General Meeting of Shareholders of June 12, 2023 and the Management Board's |
||
|---|---|---|
| statement of July 12, 2023 on the amount of share capital acquired and on determining the Company's share capital in the Articles of |
||
| Association. | ||
| August 3, 2023 | On August 3, 2023, the Company received information about the | ESPI Current |
| conditional granting of a patent by the Japanese Patent Office for the | Report No. | |
| printing apparatus used for the method of Ultra-Precise Deposition. The | 42/2023 of | |
| patent was granted in response to the patent application "Fluid printing apparatus". |
August 4, 2023 | |
| The final formal requirement for obtaining the patent is to pay the | ||
| patent fee by August 17, 2023. Should the requirement not be met, the | ||
| Company will communicate this in a separate current report. | ||
| The patent protection will increase the value of the potential | ||
| commercialization of the Company's technology with respect to the | ||
| Issuer's technological solutions for the next generation electronics | ||
| market. The reported event confirms continued delivery of the | ||
| Company's strategy of building a patent cloud for its proprietary | ||
| technology and products, which will contribute to building the Issuer's | ||
| credibility among potential industrial clients. | ||
| August 7, 2023 | On August 7, 2023, the Issuer received a notification made by Filip | ESPI Current |
| Granek, PhD, under Article 69(1)(2) of the Act on Public Offering | Report No. | |
| concerning reduction of his share in the total number of votes at the | 43/2023 of | |
| Issuer's General Meeting following the registration of the Issuer's share | August 7, 2023 | |
| capital increase by the registry court in connection with the issue of the | ||
| series V shares. | ||
| August 16, 2023 | On August 16, 2023, the Central Securities Depository of Poland | ESPI Current |
| ("KDPW") declared that it had entered into an agreement with the | Report No. | |
| Company for the registration of 275,000 series V ordinary bearer shares | 44/2023 of | |
| of the Company ("Shares"). The shares will be registered in the | August 17, 2023 | |
| securities depository operated by KDPW, provided that they are | ||
| introduced to trading on the regulated market operated by the Warsaw | ||
| Stock Exchange. The shares will be registered under the existing ISIN | ||
| code PLXTPL000018. | ||
| August 18, 2023 | On August 18, 2023, the Management Board of the Warsaw Stock | ESPI Current |
| Exchange S.A. ("WSE") adopted a resolution on the admission of | Report No. | |
| 275,000 series V ordinary bearer shares of the Company ("Shares") to | 45/2023 of | |
| trading on the regulated market operated by the WSE ("Regulated | August 21, 2023 | |
| Market") and on the conditional introduction of the Shares to trading on | ||
| the Regulated Market as of August 23 2023. The Shares were to be | ||
| introduced to trading on the Regulated Market provided that on August | ||
| 23, 2023 KDPW registered them in the securities depository under the ISIN code PLXTPL000018. |
||
| August 21, 2023 | On August 21, 2023, the Central Securities Depository of Poland | ESPI Current |
| announced that the date registration of 275,000 series V ordinary | Report No. | |
| bearer shares of the Company marked with the ISIN code PLXTPL000018 | 46/2023 of | |
| in the securities register had been set to August 23, 2023. | August 21, 2023 |

| shaping global nanofuture | ||
|---|---|---|
| -- | -- | --------------------------- |
| September 6, 2023 | On September 6, 2023, the Company confirmed another order placed | ESPI Current |
|---|---|---|
| by Yi Xin (HK) Technology Co., Ltd, based in China ["Yi Xin", | Report No. | |
| "Dystrybutor"] for the delivery of the Delta Printing System. The | 47/2023 of | |
| Company will deliver and commission the device in the first half of 2024. | September 6, | |
| 2023 | ||
| The end buyer of the device will be a leading Chinese R&D center: | ||
| Research Institute of Tsinghua University w Shenzhen, China ["End | ||
| Client"]. The XTPL device will used in work on conductive structures for | ||
| heterogeneous integration of 3D chips. | ||
| September 8, 2023 | On September 8, 2023, the Issuer and Detekt Technology Inc. with its | ESPI Current |
| registered office in Taiwan ["Detekt"] signed an agreement for the non | Report No. | |
| exclusive distribution of the Issuer's technological solutions | 48/2023 of | |
| ["Agreement"]. | September 11, | |
| 2023 | ||
| Under the Agreement, Detekt will act as a distributor of XTPL's | ||
| technological solutions in Taiwan. The purpose of the cooperation is to | ||
| support the Issuer in expanding the range of applications for the | ||
| Company's technology and products at technological corporations and | ||
| R&D centers and scientific institutions. The partnership will also increase | ||
| awareness and visibility of the Issuer's solutions among global players in | ||
| semiconductor and display technologies market. |


The (standalone) financial statements of XTPL Group cover the period of six months ended June 30, 2023, and the comparative data for the period of six months ended June 30, 2022. They were prepared using the historical cost convention. The financial statements have been prepared on the assumption that the Company will continue in operation for at least a year from the Report Date.
At the date of approval of these financial statements, the Management Board has not identified any circumstances which would point to a risk to continuity of operations in the above period.
The financial statements do not contain all the information and disclosures required of annual financial statements and should be read jointly with the annual financial statements of XTPL S.A. for 2022 as published on April 26, 2023.
The financial statements have been prepared in accordance with the International Accounting Standard ("IAS") 34 Interim Financial Reporting and in accordance with the Finance Minister's Ordinance on current and financial information.
The functional currency and reporting currency of the financial statements is the Polish zloty (PLN), and the data contained in the financial statements are presented in thousands of Polish zlotys.
| 2023 January–June |
2022 January – June/ |
|||
|---|---|---|---|---|
| December 2022 | ||||
| exchange rates used in the financial statements | EUR | USD | EUR | USD |
| for balance sheet items | 4.4503 | 4.1066 | 4.6899 | 4.4018 |
| for profit or loss and cash flow items | 4.6130 | 4.2711 | 4.6427 | 4.2744 |
For the purpose of preparing the half-yearly condensed consolidated financial statements, the same accounting principles have been used as in the last annual financial statements published on April 26, 2023, and in the last quarterly financial statements prepared as at March 31, 2023 (report for Q1 2023 of May 17, 2023).
There were no changes in the accounting policies or significant changes in estimates in the Reporting Period.

Signatures of all Management Board members
Filip Granek Jacek Olszański CEO Management Board Member
Person responsible for maintaining books of account Edward Czuchajewski Chief Accountant

The Management Board of XTPL S.A. declares that to the best of its knowledge the semi-annual standalone financial statements and the comparable data have been prepared in accordance with the applicable accounting policies and give a true, fair and clear view of the assets, financial position and profit or loss of XTPL S.A.
Signatures of all Management Board members

The Management Board of XTPL S.A. hereby declares that the audit firm authorized to examine financial statements and entrusted with the interim review of the semi-annual condensed financial statements was selected in accordance with the applicable law. The audit firm and the statutory auditors performing the review met the conditions for issuing an unbiased and independent report on the review of the interim condensed financial statements, in accordance with the applicable regulations and professional standards.
Signatures of all Management Board members
Not applicable. The auditor has not issued any qualified opinion, adverse opinion or a disclaimer of opinion about the interim condensed standalone financial statements.

The semi-annual report for the first half of 2023 ended on June 30, 2023 was approved for publication by the Management Board of the Parent Company on September 20, 2023.
Signatures of all Management Board members
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.